| Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics R Khairnar, MA Islam, J Fleishman, S Kumar Life Sciences 312, 121185, 2023 | 29 | 2023 |
| Lipocalin-Type Prostaglandin D2 Synthase Protein- A Central Player in Metabolism MA Islam, R Khairnar, J Fleishman, K Thompson, S Kumar Pharmaceutical Research 39 (11), 2951-2963, 2022 | 4 | 2022 |
| Emerging targets signaling for inflammation in Parkinson’s disease drug discovery RC Khairnar, N Parihar, KS Prabhavalkar, LK Bhatt Metabolic Brain Disease 37 (7), 2143-2161, 2022 | 2 | 2022 |
| Investigating the Intertwine Effect of Insulin Resistance and Lipocalin Prostaglandin D2 Synthase in Non-alcoholic Fatty Liver Disease using HepG2 Cells R Khairnar, MA Islam, S Kumar Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | 1 | 2023 |
| A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis M Sultana, MA Islam, R Khairnar, S Kumar Molecular and Cellular Endocrinology, 112448, 2025 | | 2025 |
| Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase MA Islam, R Khairnar, J Fleishman, SE Reznik, L Ragolia, S Gobbooru, ... Molecular and Cellular Endocrinology 595, 112404, 2025 | | 2025 |
| High Fructose-High-Fat Diet Accelerates Non-Alcoholic Fatty Liver Disease Possibly Mitigating Hepatic Nuclear Lipocalin Prostaglandin D2 Synthase R Khairnar, S Kumar Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Differential Regulation of Formyl Peptide Receptor 2 Protein in Non-alcoholic Fatty Liver Disease on High Fructose and High Fat Fed Male and Female C57BL/6 Mice MA Islam, R Khairnar, S Kumar Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |